Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.39 | 0.06 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.31 | 0.2 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.25 | 0.3 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.25 | 0.3 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.22 | 0.01 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.22 | 0.1 |